US FDA accepts Camurus’ resubmission of NDA for Oclaiz for treatment of acromegaly: Lund, Sweden Monday, January 12, 2026, 15:00 Hrs [IST] Camurus, an international, science-led ...
For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback